George is the co-founder and CSO for ImmTune. He has a broad bioscience background, covering immunology and biochemistry and cancer drug discovery. George has co-conceived the idea behind ImmTune’s technology with his co-founder Bakul.

During this PhD and subsequent postdoc he discovered and developed peptide inhibitors for intracellular proteins involved in cancerous signal dysregulation. The peptide compounds produced during his PhD have been pursued in a collaboration with MedImmune/Astra Zeneca. 

George is a gold medalist and topped Biochemistry and Immunology during his under-graduation at Trinity College Dublin. He completed his PhD and Postdoctoral work at the University of Cambridge, and has an online MBA from Quantic School of Business and Technology.